Pamisell, 20.24% ↑ on COVID-19 (Remdesivir) Theme Uptrend

On the 17th, the COVID-19 (Remdesivir) theme rose by 7.94% compared to the previous day, showing a strong performance, while Pharmicell, a related stock drawing attention, surged by 20.24% compared to the previous day. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Pharmicell ranked 2nd out of 4 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Pharmicell having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.